Literature DB >> 12949322

Successful treatment of human granulocytic ehrlichiosis in children using rifampin.

Peter J Krause1, Cathy L Corrow, Johan S Bakken.   

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging tick-borne infectious disease caused by Anaplasma phagocytophilum. Clinical features include a flu-like illness that usually resolves within 1 week. More serious infection may occur that requires hospital admission or culminates in death. Doxycycline is the treatment of choice for HGE but may cause permanent staining of teeth in children younger than 8 years of age. We report successful treatment of HGE with rifampin in 2 children, 4 and 6 years old. A course of rifampin for 5 to 7 days should be considered in children younger than 8 years of age who experience non-life-threatening A phagocytophilum infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949322     DOI: 10.1542/peds.112.3.e252

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Anaplasma phagocytophilum infection in a domestic cat in Finland: Case report.

Authors:  Helka M Heikkilä; Anna Bondarenko; Andrea Mihalkov; Kurt Pfister; Thomas Spillmann
Journal:  Acta Vet Scand       Date:  2010-11-15       Impact factor: 1.695

2.  African Tick Bite Fever Treated Successfully With Rifampin in a Patient With Doxycycline Intolerance.

Authors:  Andrew Strand; Christopher D Paddock; Alex R Rinehart; Marah E Condit; Jessica R Marus; Shezeen Gillani; Ida H Chung; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

Review 3.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 4.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilum.

Authors:  Qingming Xiong; Yasuko Rikihisa
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

6.  Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR.

Authors:  S Branger; J M Rolain; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Antibiotic clearance of Ehrlichia canis from dogs infected by intravenous inoculation of carrier blood.

Authors:  John J Schaefer; Jonathan Kahn; Glen R Needham; Yasuko Rikihisa; S A Ewing; R W Stich
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 8.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

9.  Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin.

Authors:  Khalid Abusaada; Saira Ajmal; Laura Hughes
Journal:  Cureus       Date:  2016-01-01

Review 10.  Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis.

Authors:  Rachael J Thomas; J Stephen Dumler; Jason A Carlyon
Journal:  Expert Rev Anti Infect Ther       Date:  2009-08       Impact factor: 5.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.